Drug Type Monoclonal antibody |
Synonyms Anti-CD146-monoclonal-antibody, Anti-MCAM-monoclonal-antibody, PRX-003 |
Target |
Action inhibitors |
Mechanism Muc18 inhibitors(Melanoma cell adhesion molecule inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Phase 1 | United States | 01 May 2015 | |
Inflammation | Preclinical | Ireland | - | |
Neoplasms | Preclinical | Ireland | - | |
Multiple Sclerosis | Discovery | Ireland | - |